CSCorey Alfred Stevens

Corey Alfred Stevens

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Corey Alfred Stevens has a total of 38 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    It’s not just snot!

    by Corey A Stevens, Katharina Ribbeck

    Unfairly labeled as ‘snot’ or ‘phlegm’ mucus is a biological marvel that plays a crucial role in protecting the body from pathogens and pollutants. Its multiple functions and extraordinary properties have inspired new biomaterials.


  • Polymer Blend Controls Nanoparticles’ Surface Charge for Improved Mucus Penetration and Epithelial Cell Adhesion

    by Corey A. Stevens, Boris Sevarika, Brian K. Wilson, Chia-Ming Wang, Gerardo Cárcamo-Oyarce, Joseph Romeo, George Degen, Timothy Kassis, Claus Michael Lehr, Rebecca L. Carrier, et al.

    Mucus, a viscoelastic gel composed of dense mucin glycoprotein networks, acts as a major barrier to therapeutic delivery across all epithelial surfaces by trapping nanoparticles (NPs) and preventing access to the underlying cells. To address this, we developed mucus-evading yet cell-sticky (MECS) NPs with tunable surface charge using Flash NanoPrecipitation. These 100-nanometer-diameter MECS NPs incorporate a small amount (5 wt %) of polycationic dimethylaminoethyl methacrylate (PDMAEMA) into a dense, neutral poly(ethylene glycol) (PEG) corona, which enables mucus penetration while also driving epithelial cell adhesion. In vitro cell culture and physiologically relevant gut-on-a-chip organoids demonstrate MECS NPs penetrate mucus as effectively as purely PEGylated control NPs, while exhibiting a 45-fold increase in binding to epithelial cells. This dual functionality represents a generalizable strategy for overcoming the long-standing trade-off between mucodiffusion and cellular uptake in mucosal drug delivery.


  • Measuring and Analyzing Bacterial Movement in Mucus

    by Chris Viets, Corey A. Stevens

    Humans are colonized by trillions of microbes that compose the human microbiome. Much of the microbiome inhabits the mucus layers. Mucus layers, covering digestive, reproductive, ocular, and respiratory tracts, are viscous networks consisting mainly of water and mucin glycoproteins. Mucins assemble into a dense, cross-linked network that can affect bacterial swimming patterns, and studying this behavior provides valuable insights into how the body regulates interactions with both harmful and beneficial microbes. Here we present the use of time-lapse imaging to track individual bacterial cells within mucin and discuss techniques for accurately extracting cell trajectory data from these images. By integrating theoretical and experimental approaches, we also describe how to quantify bacterial movement in terms of speed, persistence, and randomness.

  • Open Access

    A Strategic Blend of Stabilizing Polymers to Control Particle Surface Charge for Enhanced Mucus Transport and Cell Binding

    by Corey A. Stevens, Boris Sevarika, Brian K. Wilson, Chia-Ming Wang, Gerardo Cárcamo-Oyarce, George Degen, Timothy Kassis, Claus Michael Lehr, Rebecca Carrier, Katharina Ribbeck, et al.

    Mucus layers, viscoelastic gels abundant in anionic mucin glycoproteins, obstruct therapeutic delivery across all mucosal surfaces. We found that strongly positively charged nanoparticles (NPs) rapidly adsorb a mucin protein corona in mucus, impeding cell binding and uptake. To overcome this, we developed mucus-evading, cell-adhesive (MECS) NPs with variable surface charge using Flash NanoPrecipitation, by blending a neutral poly(ethylene glycol) (PEG) corona for mucus transport with a small amount, 5 wt%, of polycationic dimethylaminoethyl methacrylate (PDMAEMA) for increased cell targeting. In vitro experiments confirmed rapid mucus penetration and binding to epithelial cells by MECS NPs, suggesting a breakthrough in mucosal drug delivery.


  • Open Access

    Mucus-Inspired Self-Healing Hydrogels: A Protective Barrier for Cells against Viral Infection

    by Raju Bej, Corey Alfred Stevens, Chuanxiong Nie, Kai Ludwig, George Degen, Yannic Kerkhoff, Marina Pigaleva, Julia M. Adler, Nicole A. Bustos, Taylor M. Page, et al.

    Mucus is a dynamic biological hydrogel, composed primarily of the glycoprotein mucin, exhibits unique biophysical properties and forms a barrier protecting cells against a broad spectrum of viruses. Here we developed a polyglycerol sulfate-based dendronized mucin-inspired copolymer (MICP-1) with ~10 % repeating units of activated disulfide as cross-linking sites. Cryo-EM analysis of MICP-1 reveals an elongated single-chain fiber morphology. MICP-1 shows potential inhibitory activity against many viruses such as HSV-1 and SARS-CoV-2 (including variants such as Delta and Omicron). MICP-1 produces hydrogels with viscoelastic properties similar to healthy human sputum and with tuneable microstructures using linear and branched PEG-thiol as cross-linkers. Single particle tracking microrheology, EPR and Cryo-SEM were used to characterize the network structures. The synthesized hydrogels exhibit self-healing properties, along with viscoelastic properties that are tuneable through reduction. a transwell assay was used to investigate the hydrogel’s protective properties against viral infection against HSV-1. Live-cell microscopy confirmed that these hydrogels can protect underlying cells from infection by trapping the virus, due to both network morphology and anionic multivalent effects. Overall, our novel mucin-inspired copolymer generates mucus-mimetic hydrogels on a multi-gram scale. These hydrogels can be used as a models for disulfide-rich airway mucus research, and as biomaterials.


  • Divergent Mechanisms of Ice Growth Inhibition by Antifreeze Proteins

    by Ran Drori, Corey A. Stevens

    Antifreeze proteins (AFPs) are biomolecules that can bind to ice and hinder its growth, thus holding significant potential for biotechnological and biomedical applications. AFPs are a subset of ice-binding proteins (IBPs) and are found in various organisms across different life kingdoms. This mini-review investigates the underlying mechanisms by which AFPs impede ice growth, emphasizing the disparities between hyperactive and moderate AFPs. Hyperactive AFPs exhibit heightened thermal hysteresis (TH) activity and can bind to both the basal and prism planes of ice crystals, enabling them to endure extremely cold temperatures. In contrast, moderate AFPs predominantly bind to the prism/pyramidal planes and demonstrate lower TH activity. The structural diversity of AFPs and the presence of ordered water molecules on their ice-binding sites (IBS) have been subjects of debate among researchers. Multiple hypotheses have been proposed concerning the significance of ordered water molecules in ice binding. Gaining insights into the binding dynamics and the factors influencing TH activity in AFPs is crucial for the development of efficient synthetic compounds and the establishment of comprehensive models to elucidate ice growth inhibition. Here we emphasize the necessity for further research to unravel the mechanisms of AFPs and presents a pathway for constructing models capable of comprehensively explaining their inhibitory effects on ice growth. Key words Antifreeze proteins Adsorption rate Thermal hysteresis Hyperactive Moderate Synergy


  • Generating Ice-Binding Protein–Polymer Bioconjugates

    by Corey A. Stevens

    Protein–polymer conjugates combine the stability of polymers with the diversity, specificity, and functionality of proteins. The resulting hybrid materials can display properties not found in the individual components and can be particularly relevant for engineering new functionalities. Ice-binding proteins have many potential biotechnical and biomedical applications. However, their widespread use has been limited due to cost of production, limited activity, and relative instability. Polymer attachment has led to higher thermal hysteresis activities with less protein and superior stabilities. Thus, IBP–polymer conjugates have the ability to overcome a number of these challenges and lead to materials to tackle biomedical applications. Key words Protein polymer conjugates Hybrid materials Polymer attachment Ice-binding proteins (IBPs) Biotechnical applications Biomedical applications Thermal hysteresis


  • Open Access

    Self-assembly of protein-polymer conjugates for drug delivery

    by Corey. A. Stevens, Kuljeet Kaur, Harm-Anton Klok


  • Magnetotaxis Enables Magnetotactic Bacteria to Navigate in Flow

    by Saeed Rismani Yazdi, Reza Nosrati, Corey A. Stevens, David Vogel, Peter L. Davies, Carlos Escobedo

    Magnetotactic bacteria (MTB) play an important role in Earth's biogeochemical cycles by transporting minerals in aquatic ecosystems, and have shown promise for controlled transport of microscale objects in flow conditions. However, how MTB traverse complex flow environments is not clear. Here, using microfluidics and high‐speed imaging, it is revealed that magnetotaxis enables directed motion of Magnetospirillum magneticum over long distances in flow velocities ranging from 2 to 1260 µm s−1, corresponding to shear rates ranging from 0.2 to 142 s−1—a range relevant to both aquatic environments and biomedical applications. The ability of MTB to overcome a current is influenced by the flow, the magnetic field, and their relative orientation. MTB can overcome 2.3‐fold higher flow velocities when directed to swim perpendicular to the flow as compared to upstream, as the latter orientation induces higher drag. The results indicate a threshold drag of 9.5 pN, corresponding to a flow velocity of 550 µm s−1, where magnetotaxis enables MTB to overcome counterdirectional flow. These findings bring new insights into the interactions of MTB with complex flow environments relevant to aquatic ecosystems, while suggesting opportunities for in vivo applications of MTB in microbiorobotics and targeted drug delivery.